BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 20113885)

  • 1. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
    Heimall J; Puck J; Buckley R; Fleisher TA; Gennery AR; Neven B; Slatter M; Haddad E; Notarangelo LD; Baker KS; Dietz AC; Duncan C; Pulsipher MA; Cowan MJ
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):379-387. PubMed ID: 28068510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic hematopoietic cell transplantation: the state of the art.
    Gyurkocza B; Rezvani A; Storb RF
    Expert Rev Hematol; 2010 Jun; 3(3):285-99. PubMed ID: 20871781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized hematopoietic stem cell transplantation for inborn errors of immunity.
    Slatter M; Lum SH
    Front Immunol; 2023; 14():1162605. PubMed ID: 37090739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in the field of hematopoietic stem cell-based therapies for inborn errors of immunity.
    Arnold DE; Pai SY
    Curr Opin Pediatr; 2023 Dec; 35(6):663-670. PubMed ID: 37732933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expectations and experience: Parent and patient perspectives regarding treatment for Severe Combined Immunodeficiency (SCID).
    Smith H; Scalchunes C; Cowan MJ; Puck J; Heimall J
    Clin Immunol; 2021 Aug; 229():108778. PubMed ID: 34144198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study.
    Eissa H; Thakar MS; Shah AJ; Logan BR; Griffith LM; Dong H; Parrott RE; O'Reilly RJ; Dara J; Kapoor N; Forbes Satter L; Chandra S; Kapadia M; Chandrakasan S; Knutsen A; Jyonouchi SC; Molinari L; Rayes A; Ebens CL; Teira P; Dávila Saldaña BJ; Burroughs LM; Chaudhury S; Chellapandian D; Gillio AP; Goldman F; Malech HL; DeSantes K; Cuvelier GDE; Rozmus J; Quinones R; Yu LC; Broglie L; Aquino V; Shereck E; Moore TB; Vander Lugt MT; Mousallem TI; Oved JH; Dorsey M; Abdel-Azim H; Martinez C; Bleesing JH; Prockop S; Kohn DB; Bednarski JJ; Leiding J; Marsh RA; Torgerson T; Notarangelo LD; Pai SY; Pulsipher MA; Puck JM; Dvorak CC; Haddad E; Buckley RH; Cowan MJ; Heimall J
    J Allergy Clin Immunol; 2024 Jan; 153(1):287-296. PubMed ID: 37793572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey on retransplantation criteria for patients with severe combined immunodeficiency.
    Haddad E; Allakhverdi Z; Griffith LM; Cowan MJ; Notarangelo LD
    J Allergy Clin Immunol; 2014 Feb; 133(2):597-9. PubMed ID: 24331379
    [No Abstract]   [Full Text] [Related]  

  • 8. Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors.
    Koh LP; Rizzieri DA; Chao NJ
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1249-67. PubMed ID: 17950913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-haploidentical donor transplantation in severe combined immunodeficiency.
    Friedrich W; Hönig M
    Immunol Allergy Clin North Am; 2010 Feb; 30(1):31-44. PubMed ID: 20113885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-haploidentical donor transplantation in severe combined immunodeficiency.
    Friedrich W; Hönig M
    Hematol Oncol Clin North Am; 2011 Feb; 25(1):31-44. PubMed ID: 21236388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transplantation of highly purified CD34+ hematologic peripheral stem cells from haploidentical related donors in the treatment of children with non-malignant diseases].
    Starý J; Sedlácek P; Vodvárková S; Poloucková A; Formánková R; Gasová Z; Marinov I
    Cas Lek Cesk; 2002 Mar; 141(6):176-81. PubMed ID: 11977835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow transplantation using HLA-matched unrelated donors for patients suffering from severe combined immunodeficiency.
    Grunebaum E; Roifman CM
    Immunol Allergy Clin North Am; 2010 Feb; 30(1):63-73. PubMed ID: 20113887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-haploidentical transplantations for primary immunodeficiencies: a single-center experience.
    Cipe FE; Dogu F; Aytekin C; Yuksek M; Kendirli T; Yildiran A; Bozdogan G; Karatas D; Reisli I; Dalva K; Arpacı F; Ikinciogullari A
    Pediatr Transplant; 2012 Aug; 16(5):451-7. PubMed ID: 22594916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic stem cell transplantation for severe combined immunodeficiency diseases.
    Cowan MJ; Neven B; Cavazanna-Calvo M; Fischer A; Puck J
    Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):73-5. PubMed ID: 18162224
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.